Planate (Canada)This page contains information on Planate for veterinary use.
The information provided typically includes the following:
- Planate Indications
- Warnings and cautions for Planate
- Direction and dosage information for Planate
PlanateThis treatment applies to the following species:
Sterile Injectable prostaglandin analogue for swine
Veterinary Use Only
PLANATE (cloprostenol) is a synthetic prostaglandin analogue for use in swine.
Each 2 mL dose of the colorless solution contains:
175 µg of cloprostenol (as cloprostenol sodium USP)
0.1% w/v chlorocresol
PLANATE induces farrowing in sows and gilts. Parturition and piglet viability are normal when PLANATE is administered as early as 1 or 2 days before the expected farrowing date. Piglet mortality may be increased if PLANATE is administered earlier than the second day before expected farrowing. The prediction of the precise date of farrowing is subject to error; therefore, the operator should be prepared to render extra care to piglets, if necessary. The average gestation length must be calculated on each farm from accurate service records so that sows may be induced to farrow at the required time. (In most situations gestation length varies between 111 and 119 days with an average around 115 days as shown below.) Sows and gilts may then be given PLANATE as early in gestation as 2 days before this calculated expected farrowing date. The majority of animals can be expected to respond within the period 24 ± 5 hours following injection, except in those cases where spontaneous farrowing is imminent. Trials have shown that normally 95% will commence farrowing within 36 hours of treatment.
Planate Dosage And Administration
2 mL (175 µg cloprostenol). PLANATE should be administered by deep intramuscular injection.
An increase in the number of nonviable piglets may result if PLANATE is used more than two days prior to the average gestation length calculated from farm records.
Treated animals must not be slaughtered for use in food for at least 7 days after the latest treatment with this drug.
This product should be handled carefully to avoid accidental self-injection or contact with the skin or mucous membranes of the user.
Prostaglandins of the F2α type may readily be absorbed through the skin and may cause bronchospasms and/or miscarriage.
Pregnant women, women of childbearing age, asthmatics and people with other respiratory tract diseases should exercise extreme caution when handling this product such as wearing waterproof gloves.
Accidental spillage on the skin should be washed off immediately with water.
In case of accidental self-injection, seek medical advice and show the package insert to the doctor. Should respiratory distress result from accidental inhalation or injection, the inhalation of a rapidly acting bronchodilator is indicated.
Keep out of reach of children.
Mild side effects (consisting of exaggerated nesting behavior and restlessness) may be seen occasionally.
Protect from light. Store between 15° and 30°C.
20 mL multi dose vials.
Intervet Canada Corp., subsidiary of Merck & Co., Inc., 16750, route Transcanadienne, Kirkland, QC H9H 4M7
® Registered trademark of Intervet Inc. Used under license.
Version 22 August 2013
NAC No.: 1208076.6
Intervet Canada Corp.
16750 ROUTE TRANSCANADIENNE, KIRKLAND, QC, H9H 4M7
|Fax:||Toll-free 888-498-4444; local 514-428-7014|
|Every effort has been made to ensure the accuracy of the Planate information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.|
Copyright © 2015 North American Compendiums. Updated: 2015-04-03